Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report

An increase in triglyceride levels in familial hyperlipidemia during pregnancy has been reported. Severe hypertriglyceridemia can lead to complications such as acute pancreatitis, preeclampsia, maternal and fetal complications. Because of the teratogenic effects associated with fibrate therapy in pr...

Full description

Bibliographic Details
Main Authors: Mustafa Kemal Balcı, Hasan Altunbaş, Nusret Yılmaz, Güven Barış Cansu, Ramazan Sarı
Format: Article
Language:English
Published: Galenos Publishing House 2012-06-01
Series:Balkan Medical Journal
Subjects:
Online Access:http://balkanmedicaljournal.org/text.php3?id=869
_version_ 1797922582830252032
author Mustafa Kemal Balcı
Hasan Altunbaş
Nusret Yılmaz
Güven Barış Cansu
Ramazan Sarı
author_facet Mustafa Kemal Balcı
Hasan Altunbaş
Nusret Yılmaz
Güven Barış Cansu
Ramazan Sarı
author_sort Mustafa Kemal Balcı
collection DOAJ
description An increase in triglyceride levels in familial hyperlipidemia during pregnancy has been reported. Severe hypertriglyceridemia can lead to complications such as acute pancreatitis, preeclampsia, maternal and fetal complications. Because of the teratogenic effects associated with fibrate therapy in pregnancy, alternative treatment strategies such as insulin as a rapid and potent activator of lipoprotein lipase are required during pregnancy. We report a case of hypertriglyceridemia in a 33-year-old pregnant woman in whom treatment with merely single one time administration of Neutral Protamine Hagedorn insulin was accompanied by a reduction in the serum triglyceride level; to the best of our knowledge, this has never been reported in the literature. Her triglyceride level was 3616 mg/dL before insulin treatment and 1246 mg/dL after insulin treatment. Although this regimen was used safely and effectively in our patient, comprehensive studies are required to evaluate the effectiveness and safety of subcutaneously intermediate-acting Neutral Protamine Hagedorn insulin for the treatment of severe hypertriglyceridemia in non-diabetic pregnant women.
first_indexed 2024-04-10T14:34:42Z
format Article
id doaj.art-2682ddcf20044cada715656ebee7d99b
institution Directory Open Access Journal
issn 2146-3123
2146-3131
language English
last_indexed 2024-04-10T14:34:42Z
publishDate 2012-06-01
publisher Galenos Publishing House
record_format Article
series Balkan Medical Journal
spelling doaj.art-2682ddcf20044cada715656ebee7d99b2023-02-15T16:08:40ZengGalenos Publishing HouseBalkan Medical Journal2146-31232146-31312012-06-01292222224Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case ReportMustafa Kemal BalcıHasan AltunbaşNusret YılmazGüven Barış CansuRamazan SarıAn increase in triglyceride levels in familial hyperlipidemia during pregnancy has been reported. Severe hypertriglyceridemia can lead to complications such as acute pancreatitis, preeclampsia, maternal and fetal complications. Because of the teratogenic effects associated with fibrate therapy in pregnancy, alternative treatment strategies such as insulin as a rapid and potent activator of lipoprotein lipase are required during pregnancy. We report a case of hypertriglyceridemia in a 33-year-old pregnant woman in whom treatment with merely single one time administration of Neutral Protamine Hagedorn insulin was accompanied by a reduction in the serum triglyceride level; to the best of our knowledge, this has never been reported in the literature. Her triglyceride level was 3616 mg/dL before insulin treatment and 1246 mg/dL after insulin treatment. Although this regimen was used safely and effectively in our patient, comprehensive studies are required to evaluate the effectiveness and safety of subcutaneously intermediate-acting Neutral Protamine Hagedorn insulin for the treatment of severe hypertriglyceridemia in non-diabetic pregnant women.http://balkanmedicaljournal.org/text.php3?id=869Pregnancyhypertriglyceridemiainsulin
spellingShingle Mustafa Kemal Balcı
Hasan Altunbaş
Nusret Yılmaz
Güven Barış Cansu
Ramazan Sarı
Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report
Balkan Medical Journal
Pregnancy
hypertriglyceridemia
insulin
title Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report
title_full Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report
title_fullStr Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report
title_full_unstemmed Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report
title_short Subcutaneous NPH Insulin for Severe Hypertriglyceridemia in a Pregnant Patient with Type V Hyperlipoproteinemia: a Case Report
title_sort subcutaneous nph insulin for severe hypertriglyceridemia in a pregnant patient with type v hyperlipoproteinemia a case report
topic Pregnancy
hypertriglyceridemia
insulin
url http://balkanmedicaljournal.org/text.php3?id=869
work_keys_str_mv AT mustafakemalbalcı subcutaneousnphinsulinforseverehypertriglyceridemiainapregnantpatientwithtypevhyperlipoproteinemiaacasereport
AT hasanaltunbas subcutaneousnphinsulinforseverehypertriglyceridemiainapregnantpatientwithtypevhyperlipoproteinemiaacasereport
AT nusretyılmaz subcutaneousnphinsulinforseverehypertriglyceridemiainapregnantpatientwithtypevhyperlipoproteinemiaacasereport
AT guvenbarıscansu subcutaneousnphinsulinforseverehypertriglyceridemiainapregnantpatientwithtypevhyperlipoproteinemiaacasereport
AT ramazansarı subcutaneousnphinsulinforseverehypertriglyceridemiainapregnantpatientwithtypevhyperlipoproteinemiaacasereport